PubMed:32727845
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 26-36 | SP_7 | denotes | SARS-CoV-2 |
T2 | 54-60 | SO:0000417 | denotes | domain |
T3 | 70-75 | SP_6 | denotes | human |
T4 | 70-75 | NCBITaxon:9606 | denotes | human |
T5 | 87-95 | GO:0042571 | denotes | antibody |
T6 | 222-232 | SP_7 | denotes | SARS-CoV-2 |
T7 | 314-324 | GO:0042571 | denotes | antibodies |
T8 | 342-347 | NCBITaxon:10239 | denotes | viral |
T9 | 348-356 | BV_9 | denotes | epitopes |
T10 | 358-363 | SP_6 | denotes | Human |
T11 | 358-363 | NCBITaxon:9606 | denotes | Human |
T12 | 450-460 | GO:0042571 | denotes | antibodies |
T13 | 564-574 | GO:0042571 | denotes | antibodies |
T14 | 606-612 | SO:0000417 | denotes | domain |
T15 | 663-668 | SP_6 | denotes | human |
T16 | 663-668 | NCBITaxon:9606 | denotes | human |
T17 | 760-772 | SO:0000984 | denotes | single chain |
T18 | 853-861 | GO:0042571 | denotes | antibody |
T19 | 904-912 | GO:0042571 | denotes | antibody |
T20 | 980-988 | CHEBI:59132 | denotes | antigens |
T21 | 980-988 | CHEBI:59132 | denotes | antigens |
T22 | 1099-1109 | GO:0010467 | denotes | expressing |
T23 | 1110-1118 | GO:0016020 | denotes | membrane |
T24 | 1199-1206 | BV_9 | denotes | epitope |
T25 | 1236-1267 | PG_10 | denotes | angiotensin converting enzyme 2 |
T26 | 1236-1267 | PR:000003622 | denotes | angiotensin converting enzyme 2 |
T27 | 1269-1273 | G_3 | denotes | ACE2 |
T28 | 1269-1273 | PG_10 | denotes | ACE2 |
T29 | 1269-1273 | PR:000003622 | denotes | ACE2 |
T30 | 1388-1398 | GO:0042571 | denotes | antibodies |
T31 | 1426-1434 | CHEBI:33893 | denotes | reagents |
T32 | 1426-1434 | CHEBI:33893 | denotes | reagents |
T33 | 1511-1519 | GO:0042571 | denotes | antibody |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 87-95 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T2 | 853-861 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T3 | 904-912 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T4 | 1093-1098 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T5 | 1137-1144 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T6 | 1511-1519 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 26-34 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 222-230 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 70-75 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T2 | 101-102 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 142-143 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 358-363 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T5 | 389-392 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T6 | 655-656 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T7 | 663-668 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T8 | 744-745 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 876-878 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T10 | 1093-1098 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T11 | 1110-1118 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 980-988 | Chemical | denotes | antigens | http://purl.obolibrary.org/obo/CHEBI_59132 |
T2 | 1137-1144 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T3 | 1199-1206 | Chemical | denotes | epitope | http://purl.obolibrary.org/obo/CHEBI_53000 |
T4 | 1236-1247 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T5 | 1426-1434 | Chemical | denotes | reagents | http://purl.obolibrary.org/obo/CHEBI_33893 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 31-36 | Species | denotes | CoV-2 | Tax:2697049 |
3 | 70-75 | Species | denotes | human | Tax:9606 |
18 | 227-232 | Species | denotes | CoV-2 | Tax:2697049 |
19 | 358-363 | Species | denotes | Human | Tax:9606 |
20 | 622-627 | Species | denotes | CoV-2 | Tax:2697049 |
21 | 663-668 | Species | denotes | human | Tax:9606 |
22 | 799-803 | Gene | denotes | scFv | Gene:652070 |
23 | 810-814 | Gene | denotes | scFv | Gene:652070 |
24 | 871-875 | Gene | denotes | scFv | Gene:652070 |
25 | 1180-1184 | Gene | denotes | scFv | Gene:652070 |
26 | 1236-1267 | Gene | denotes | angiotensin converting enzyme 2 | Gene:59272 |
27 | 1269-1273 | Gene | denotes | ACE2 | Gene:59272 |
28 | 1382-1387 | Species | denotes | CoV-2 | Tax:2697049 |
29 | 1559-1564 | Species | denotes | CoV-2 | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-132 | Sentence | denotes | Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a naïve semi-synthetic library. |
T2 | 133-357 | Sentence | denotes | There is a desperate need for safe and effective vaccines, therapies and diagnostics for SARS-CoV-2, the development of which will be aided by the discovery of potent and selective antibodies against relevant viral epitopes. |
T3 | 358-517 | Sentence | denotes | Human phage display technology has revolutionized the process of identifying and optimizing antibodies, providing facile entry points for further applications. |
T4 | 518-628 | Sentence | denotes | Here in, we use this technology to search for antibodies targeting the receptor binding domain (RBD) of CoV-2. |
T5 | 629-805 | Sentence | denotes | Specifically, we screened a naïve human semi-synthetic phage library against RBD, leading to the identification of a high-affinity single chain fragment variable region (scFv). |
T6 | 806-889 | Sentence | denotes | The scFv was further engineered into two other antibody formats (scFv-Fc and IgG1). |
T7 | 890-1016 | Sentence | denotes | All the three antibody formats showed high binding specificity to CoV-2 RBD and the spike antigens in different assay systems. |
T8 | 1017-1145 | Sentence | denotes | Flow cytometry analysis demonstrated specific binding of the IgG1 format to cells expressing membrane bound CoV-2 spike protein. |
T9 | 1146-1310 | Sentence | denotes | Docking studies revealed that the scFv recognizes an epitope that partially overlaps with angiotensin converting enzyme 2 (ACE2)-interacting sites on the CoV-2 RBD. |
T10 | 1311-1565 | Sentence | denotes | Given its high specificity and affinity, we anticipate that these anti-CoV-2 antibodies will be useful as valuable reagents for accessing the antigenicity of vaccine candidates, as well as developing antibody-based therapeutics and diagnostics for CoV-2. |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-132 | Sentence | denotes | Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a naïve semi-synthetic library. |
T2 | 133-357 | Sentence | denotes | There is a desperate need for safe and effective vaccines, therapies and diagnostics for SARS-CoV-2, the development of which will be aided by the discovery of potent and selective antibodies against relevant viral epitopes. |
T3 | 358-517 | Sentence | denotes | Human phage display technology has revolutionized the process of identifying and optimizing antibodies, providing facile entry points for further applications. |
T4 | 518-628 | Sentence | denotes | Here in, we use this technology to search for antibodies targeting the receptor binding domain (RBD) of CoV-2. |
T5 | 629-805 | Sentence | denotes | Specifically, we screened a naïve human semi-synthetic phage library against RBD, leading to the identification of a high-affinity single chain fragment variable region (scFv). |
T6 | 806-889 | Sentence | denotes | The scFv was further engineered into two other antibody formats (scFv-Fc and IgG1). |
T7 | 890-1016 | Sentence | denotes | All the three antibody formats showed high binding specificity to CoV-2 RBD and the spike antigens in different assay systems. |
T8 | 1017-1145 | Sentence | denotes | Flow cytometry analysis demonstrated specific binding of the IgG1 format to cells expressing membrane bound CoV-2 spike protein. |
T9 | 1146-1310 | Sentence | denotes | Docking studies revealed that the scFv recognizes an epitope that partially overlaps with angiotensin converting enzyme 2 (ACE2)-interacting sites on the CoV-2 RBD. |
T10 | 1311-1565 | Sentence | denotes | Given its high specificity and affinity, we anticipate that these anti-CoV-2 antibodies will be useful as valuable reagents for accessing the antigenicity of vaccine candidates, as well as developing antibody-based therapeutics and diagnostics for CoV-2. |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 614-617 | Phenotype | denotes | RBD | HP:5200291 |
T2 | 706-709 | Phenotype | denotes | RBD | HP:5200291 |
T3 | 962-965 | Phenotype | denotes | RBD | HP:5200291 |
T4 | 1306-1309 | Phenotype | denotes | RBD | HP:5200291 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 26-36 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 222-232 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 26-34 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T2 | 70-75 | OrganismTaxon | denotes | human | 9606 |
T3 | 222-230 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T4 | 358-363 | OrganismTaxon | denotes | Human | 9606 |
T5 | 663-668 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1110-1118 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |